Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer REPLY

被引:0
作者
Shahinian, Vahakn B. [1 ]
Kuo, Yong-Fang [2 ]
Gilbert, Scott M. [3 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Texas Med Branch, Galveston, TX USA
[3] Univ Florida, Gainesville, FL USA
关键词
RISK;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:580 / 580
页数:1
相关论文
共 50 条
[41]   Nutrition services during prostate cancer androgen deprivation therapy [J].
Baguley, Brenton ;
Smith-Gillis, Caity ;
Porter, Judi ;
Kiss, Nicole ;
Ugalde, Anna .
BMJ SUPPORTIVE & PALLIATIVE CARE, 2023,
[42]   Androgen deprivation therapy of prostate cancer from a geriatric perspective [J].
Wiedemann, A. ;
Becher, K. ;
Manseck, A. ;
Stein, J. ;
Froehner, M. ;
Fiebig, C. ;
Piotrowski, A. ;
Kirschner-Hermanns, R. ;
Bannowsky, A. ;
Wirz, S. ;
Salem, J. ;
Kuru, T. H. .
ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2025, 58 (04) :324-335
[43]   The Role of Primary Androgen Deprivation Therapy in Localized Prostate Cancer [J].
Wong, Yu-Ning ;
Freedland, Stephen J. ;
Egleston, Brian ;
Vapiwala, Neha ;
Uzzo, Robert ;
Armstrong, Katrina .
EUROPEAN UROLOGY, 2009, 56 (04) :609-616
[44]   Effect of Prior Local Treatment and Prostate-Specific Antigen Kinetics during Androgen-Deprivation Therapy on the Survival of Castration-Resistant Prostate Cancer [J].
Hah, Yoon Soo ;
Lee, Jong Soo ;
Rha, Koon Ho ;
Hong, Sung Joon ;
Ha Chung, Byung ;
Koo, Kyo Chul .
SCIENTIFIC REPORTS, 2019, 9 (1)
[45]   The search for alternative androgen-deprivation therapies [J].
Saad, Fred .
LANCET ONCOLOGY, 2013, 14 (04) :267-268
[46]   Measuring the Effectiveness of Androgen-Deprivation Therapy for Prostate Cancer in the Medicare Population Adequate Data Are Neither the Same as Nor the Enemy of Perfect Data [J].
Quoc-Dien Trinh ;
Schrag, Deborah .
JAMA INTERNAL MEDICINE, 2014, 174 (09) :1468-1469
[47]   Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study [J].
Kim, Jae Heon ;
Bae, Gi Hwan ;
Jung, Jaehun ;
Noh, Tae Il .
WORLD JOURNAL OF MENS HEALTH, 2025, 43 (01) :123-133
[48]   Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy [J].
Huang, Shu-Pin ;
Bao, Bo-Ying ;
Wu, Ming-Tsang ;
Choueiri, Toni K. ;
Goggins, William B. ;
Liu, Chia-Chu ;
Huang, Chao-Yuan ;
Pu, Yeong-Shiau ;
Yu, Chia-Cheng ;
Wu, Tony T. ;
Huang, Chun-Nung ;
Huang, Chun-Hsiung ;
Wu, Wen-Jeng .
AGING MALE, 2012, 15 (01) :34-41
[49]   Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review [J].
Kim, Tae Jin ;
Koo, Kyo Chul .
CANCERS, 2020, 12 (06) :1-16
[50]   Androgen deprivation treatment in prostate cancer [J].
Thomas, Benjamin C. ;
Neal, David E. .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346